Journal of Substance Abuse Treatment
Volume 39, Issue 2 , Pages 141-149 , September 2010

The cost of concordance with opiate substitution treatment guidelines

  • Paul G. Barnett, Ph.D.

      Affiliations

    • VA Health Economics Resource Center (HERC), VA Palo Alto Health Care System, CA 94025, USA
    • Center for Health Care Evaluation, VA Palo Alto Health Care System, CA 94025, USA
    • Department of Health Research & Policy, Stanford University School of Medicine, Stanford, CA 94305, USA
    • Corresponding Author InformationCorresponding author. Health Economics Resource Center, VA Palo Alto Health Care System (152), Menlo Park, CA 94025, USA. Tel.: +1 650 493 5000x2 2475; fax: +1 650 617 2639.
    • ,
  • Jodie A. Trafton, Ph.D.

      Affiliations

    • Center for Health Care Evaluation, VA Palo Alto Health Care System, CA 94025, USA
    • Department of Psychiatry, Stanford University School of Medicine, Stanford, CA 94305, USA
    • ,
  • Keith Humphreys, Ph.D.

      Affiliations

    • Center for Health Care Evaluation, VA Palo Alto Health Care System, CA 94025, USA
    • Department of Psychiatry, Stanford University School of Medicine, Stanford, CA 94305, USA

Received 28 October 2009 ,Revised 17 March 2010 ,Accepted 3 May 2010.

References 

  1. American Psychiatric Association . Position statement on methadone maintenance treatment. The American Journal of Psychiatry. 1994;151:792–794
  2. Ball JC, Ross A. The effectiveness of methadone maintenance treatment. New York: Springer-Verlag; 1991;
  3. Barnett PG, Masson CL, Sorensen JL, Wong W, Hall S. Linking opioid-dependent hospital patients to drug treatment: Health care use and costs 6 months after randomization. Addiction. 2006;101:1797–1804
  4. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics. 2002;21:271–292
  5. Brugal MT, Domingo-Salvany A, Puig R, Barrio G, Garcia de Olalla P, de la Fuente L. Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain. Addiction. 2005;100:981–989
  6. Clausen T, Anchersen K, Waal H. Mortality prior to, during and after opioid maintenance treatment (OMT): A national prospective cross-registry study. Drug and Alcohol Dependence. 2008;94:151–157
  7. D'Aunno T, Pollack HA. Changes in methadone treatment practices: Results from a national panel study, 1988–2000. Jama. 2002;288:850–856
  8. Esteban J, Gimeno C, Barril J, Aragones A, Climent JM, de la Cruz Pellin M. Survival study of opioid addicts in relation to its adherence to methadone maintenance treatment. Drug and Alcohol Dependence. 2003;70:193–200
  9. Fugelstad A, Stenbacka M, Leifman A, Nylander M, Thiblin I. Methadone maintenance treatment: The balance between life-saving treatment and fatal poisonings. Addiction. 2007;102:406–412
  10. Gerstein DR, Johnson RA, Harwood H, Fountain D, Suter N, Malloy K. Evaluating recovery services: The California Drug and Alcohol Treatment Assessment (CALDATA). Sacramento, CA: California Department of Alcohol and Drug Programs; 1994;
  11. Hoffmann NG, DeHart SS, Fulkerson JA. Medical care utilization as a function of recovery status following chemical addictions treatment. Journal of Addictive Diseases. 1993;12:97–108
  12. Holder HD, Blose JO. The reduction of health care costs associated with alcoholism treatment: A 14-year longitudinal study. Journal of Studies on Alcohol. 1992;53:293–302
  13. Humphreys K, Trafton JA, Oliva EM. Does following research-derived practice guidelines improve opiate-dependent patients' outcomes under everyday practice conditions? Results of the Multisite Opiate Substitution Treatment study. Journal of Substance Abuse Treatment. 2008;34:173–179
  14. Kazis LE, Ren XS, Lee A, Skinner K, Rogers W, Clark J, et al. Health status in VA patients: Results from the Veterans Health Study. American Journal of Medical Quality. 1999;14:28–38
  15. Kraft MK, Rothbard AB, Hadley TR, McLellan AT, Asch DA. Are supplementary services provided during methadone maintenance really cost-effective?. The American Journal of Psychiatry. 1997;154:1214–1219
  16. Mark TL, Woody GE, Juday T, Kleber HD. The economic costs of heroin addiction in the United States. Drug and Alcohol Dependence. 2001;61:195–206
  17. Masson CL, Sorensen JL, Batki SL, Okin R, Delucchi KL, Perlman DC. Medical service use and financial charges among opioid users at a public hospital. Drug and Alcohol Dependence. 2002;66:45–50
  18. McLellan AT, Arndt IO, Metzger DS, Woody GE, O'Brien CP. The effects of psychosocial services in substance abuse treatment. JAMA. 1993;269:1953–1959
  19. McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, et al. The fifth edition of the Addiction Severity Index. Journal of Substance Abuse Treatment. 1992;9:199–213
  20. Metzger DS, Navaline H, Woody GE. Drug abuse treatment as AIDS prevention. Public Health Reports. 1998;113:97–106
  21. NIH Consensus Conference . Effective medical treatment of opiate addiction. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. JAMA. 1998;280:1936–1943
  22. Rosenheck R, Gallup P, Frisman LK. Health care utilization and costs after entry into an outreach program for homeless mentally ill veterans. Hospital & Community Psychiatry. 1993;44:1166–1171
  23. Trafton JA, Humphreys K, Harris AH, Oliva E. Consistent adherence to guidelines improves opioid dependent patients' first year outcomes. Journal of Behavioral Health Services & Research. 2007;34:260–271
  24. Trafton JA, Minkel J, Humphreys K. Determining effective methadone doses for individual opioid-dependent patients. PLoS Med. 2006;3:e80
  25. U.S. Department of Veterans Affairs and Department of Defense . VHA/DOD clinical practice guidelines for the management of substance use disorders in the primary care setting. Version 1.0. 2004;Washington, D.C.
  26. U.S. General Accounting Office . Methadone maintenance: Some treatment programs are not effective; Greater federal oversight needed (No. GAO/HRD-90-104). Washington, DC: U.S. General Accounting Office; 1990;
  27. Willenbring ML, Hagedorn HJ, Postier AC, Kenny M. Variations in evidence-based clinical practices in nine United States Veterans Administration opioid agonist therapy clinics. Drug and Alcohol Dependence. 2004;75:97–106
  28. Zaric GS, Barnett PG, Brandeau ML. HIV transmission and the cost-effectiveness of methadone maintenance. American Journal of Public Health. 2000;90:1100–1111
  29. Zarkin GA, Dunlap LJ, Homsi G. The substance abuse services cost analysis program (SASCAP): A new method for estimating drug treatment services cost. Evaluation and Program Planning. 2004;23:35–43
  30. Zywiak WH, Hoffmann NG, Stout RL, Hagberg S, Floyd AS, DeHart SS. Substance abuse treatment cost offsets vary with gender, age, and abstinence likelihood. J Health Care Finance. 1999;26:33–39

PII: S0740-5472(10)00116-9

doi: 10.1016/j.jsat.2010.05.012

Journal of Substance Abuse Treatment
Volume 39, Issue 2 , Pages 141-149 , September 2010

Article Tools